Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification
- PMID: 17016145
- DOI: 10.1097/01.mcg.0000225609.63975.6f
Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification
Abstract
Goals: The aim of this study was to examine and clarify the preoperative markers that are useful for differentiating between benign and malignant lesions of intraductal papillary-mucinous neoplasms (IPMN) of the pancreas, grouped according to morphologic classification.
Background: There are various stages of pathology in IPMN, ranging from benign to malignant lesions. Although the determination of appropriate treatment guidelines to deal with IPMN is a critical issue, no such guidelines have been established.
Patients and methods: One hundred twenty cases of IPMN were classified morphologically into either main or branch duct types. We compared the morphologic classification with histopathologic diagnosis using indicators of malignancy detected by imaging such as main duct diameter, the number and diameter of cysts, and the presence or absence of mural nodules. We also examined the usefulness of pancreatic juice cytology and measurement of telomerase activity as indicators of malignancy. Finally, we performed a survival analysis on the basis of morphologic classification to determine prognosis of IPMN.
Results: Whereas a high incidence (64%) of malignant lesions was seen in main duct type IPMN, benign lesions were dominant (80.5%) in branch duct type IPMN. Survival analysis showed that the prognosis was significantly worse in main duct type than in branch duct type IPMN. The lesions were aggravated in all patients with main duct type who did not undergo resection, resulting in death due to progression of the pancreatic lesion. The incidence of mural nodules was a useful indicator in main duct type, whereas main duct diameter and incidence of mural nodules were useful indicators in branch duct type. Although pancreatic juice cytology showed a high accuracy rate with low sensitivity for determining malignancy, measurement of telomerase activity in this juice was very effective for differentiating between benign and malignant lesions.
Conclusions: The incidence of malignant lesions was extremely high in main duct type IPMN, indicating that surgery is required in all these patients. However, to determine whether surgery is indicated in branch duct type IPMN it is necessary to obtain an appropriate image diagnosis focusing on main duct diameter and mural nodules and also to carry out cytology and measurement of telomerase activity in samples of pancreatic juice.
Similar articles
-
Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.Arch Surg. 2009 Apr;144(4):345-9; discussion 349-50. doi: 10.1001/archsurg.2009.2. Arch Surg. 2009. PMID: 19380648
-
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.Ann Surg. 2007 Oct;246(4):644-51; discussion 651-4. doi: 10.1097/SLA.0b013e318155a9e5. Ann Surg. 2007. PMID: 17893501
-
The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.Ann Surg. 2012 Mar;255(3):517-22. doi: 10.1097/SLA.0b013e3182444231. Ann Surg. 2012. PMID: 22301608
-
[Presentation, treatment and prognosis of intraductal papillary mucinous neoplasm].Ann Ital Chir. 2007 Jul-Aug;78(4):257-64. Ann Ital Chir. 2007. PMID: 17990599 Review. Italian.
-
Intraductal papillary mucinous neoplasms of the pancreas.Eur J Surg Oncol. 2007 Aug;33(6):678-84. doi: 10.1016/j.ejso.2006.11.031. Epub 2007 Jan 4. Eur J Surg Oncol. 2007. PMID: 17207960 Review.
Cited by
-
Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.J Korean Med Sci. 2011 Jun;26(6):740-6. doi: 10.3346/jkms.2011.26.6.740. Epub 2011 May 18. J Korean Med Sci. 2011. PMID: 21655058 Free PMC article.
-
[Branch duct intraductal papillary mucinous neoplasm - surgical approach].Chirurg. 2017 Nov;88(11):927-933. doi: 10.1007/s00104-017-0491-3. Chirurg. 2017. PMID: 28801818 Review. German.
-
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.Gut. 2007 Aug;56(8):1041-4. doi: 10.1136/gut.2006.113068. Gut. 2007. PMID: 17625140 Free PMC article.
-
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection.Gastroenterology. 2007 Jul;133(1):72-9; quiz 309-10. doi: 10.1053/j.gastro.2007.05.010. Epub 2007 May 10. Gastroenterology. 2007. PMID: 17631133 Free PMC article.
-
Imaging modalities for characterising focal pancreatic lesions.Cochrane Database Syst Rev. 2017 Apr 17;4(4):CD010213. doi: 10.1002/14651858.CD010213.pub2. Cochrane Database Syst Rev. 2017. PMID: 28415140 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical